Navigation Links
Visian® ICL and Toric ICL V4c Receive CE Mark Approval
Date:4/25/2011

ual disturbances which proved to provide the same excellent results documented with the Visian ICL technology.  Dr. Shimizu has continued to use the technology in additional patients since completing his study.

"We appreciate very much the clinical work and advice of Dr. Shimizu and other leading Visian ICL surgeons, who were instrumental in bringing this very significant improvement to the market," said STAAR Surgical CEO Barry G.  Caldwell.  "This technology marks another key advancement from our product pipeline of planned new features designed to provide continuous enhancements to the Visian ICL technology.  Late last year we launched the V4b ICL model in CE Mark countries, which expanded the range of approved treatment zones on the myopic, hyperopic and Toric models of the ICL.  This added range of treatment has already resulted in increased usage of the product in those markets."

"We are off to a good start in 2011 with strong sales of the ICL products outside the U.S.," continued Mr. Caldwell.  "This CE Mark approval positions us to build further on this momentum this year.  In addition, the V5 model is currently underway with our Research and Development team and the concept designs for the V6 model are in the feasibility phase.  I would also like to thank and congratulate our R&D and Regulatory teams, which worked together to bring the V4c technology to market earlier than originally anticipated."

The V4c model has been approved in the -0.5 diopter to -18.0 diopters myopic range and +0.5 cylinder power to +6.0 for the Toric ICL models.  The Company plans to first engage a pre-market release of the product in four sites and 100 eyes before a full launch to the markets that accept CE Mark Approvals.  In some of the key Asia Pacific markets that have not yet launched the V4b model, the Company plans to seek approval of the V4c and move directly to this new model.

About STA
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
2. The Me-Covery: Saatchi & Saatchi Wellness and Time Inc.s Health Brand Reveal Historic Shift in Female Consumer Behavior
3. Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law
4. AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides
5. More Than 30 Defendants Indicted on Prescription Pill Charges in Historic Drug Sweep
6. AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study
7. Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship
8. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
9. Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
10. ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
11. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... , March 4, 2015 Aethlon Medical, Inc. (OTCQB:AEMD), ... infectious diseases and cancer, today announced that James ... present a corporate overview at the 27th Annual ROTH ... in Laguna Niguel, California . To ... http://www.roth.com/main/page.aspx?PageID=7207 ). A live webcast of the ...
(Date:3/4/2015)... 4, 2015  Heska Corporation (Nasdaq: HSKA ... to Join Its Fourth Quarter and Year End 2014 ... @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Earnings Call link on the front page of this ... the web at the address above.  Alternatively, you may ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... Feb. 1, 2011 A breakthrough in stroke research ... stroke survivors has published today. In the February 1, ... the first human results of a new method of ... Rapid improvement in impaired motor function, gait, hand function, ...
... SHENZHEN, China, Feb. 1, 2011 /PRNewswire-Asia/ -- ... rapidly growing international trading company in China, ... possible prospective business partners today, as the ... moving towards the final signing of future ...
Cached Medicine Technology:Inflammation Identified as New Therapeutic Target Years After Stroke 2Ongoing Negotiation on Top Brand Health Device Cooperation 2
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host ... of the print publication. Mai embraces the overall theme of ... for clothes and personal care products. In an exclusive interview, ... to an organic diet. She mentions, “Having an organic lifestyle ... but also now as I’m a full time student at ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously the ... Visiopharm Board of Directors as Chairman. Mr. ... positioned to become the fastest growing software company, specializing ... , "Over the last several years, Visiopharm ... ONCOtopix™ Dx, a complete quantitative digital pathology solution for ...
(Date:3/4/2015)... March 04, 2015 Problem Gambling Awareness ... to join individuals and organizations across the nation in ... public, health care professionals, policymakers, and others about problem ... on Compulsive Gambling (FCCG) and FCCG partner organizations are ... screen patients for a gambling problem, to make treatment ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
(Date:3/4/2015)... 04, 2015 Dietary supplement company ... world’s first biocompatible copper chelate, at Natural Products Expo ... the chance to gain insight into their wellness through ... Cunermuspir complex can support their individual nutritional needs, all ... is the core ingredient of the MitoSynergy product line, ...
Breaking Medicine News(10 mins):Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2
... scientists have said that degradation of the eco systems// of ... and may cause greater harm in next 50 years. ... a major outbreak and new diseases are emerging because of ... being used in unsustainable way. ,The report emphasizes that ...
... drug raloxifene, used for treating osteoporosis is also able to ... are in their postmenopausal age. ,The study observed women ... mg of raloxifene daily for bone fractures due to osteoporosis ... After three years, all women were tested for cognitive impairments ...
... completed the second phase of testing of the vaccine ... cervical cancers and 90% of genital warts. ,277 ... 36 months and regularly had gynecological examination, cervicovaginal sampling ... antibodies to HPV. , ,The results showed the ...
... onions may be the key to avoid the risk of ... in onions, a peptide called GPCS that seems to prevent ... cells of newborn mice that were treated with parathyroid hormone ... exposed to the peptide GPCS. The treatment with the peptide ...
... In a study trying to find out the relationship between ... 585 confirmed cases of pancreatic cancer and 4779 healthy people ... pancreas is pancreatic cancer and it spreads through the lymphatic ... smoking etc had been known to increase the risk of ...
... the risk of diabetes. Obese people may be a t ... A study by UT Southwestern Medical Center of US suggests ... have a genetic component. ,The study had evaluated ... type II in people. The study was conducted on 679 ...
Cached Medicine News:
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size....
Medicine Products: